Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

zosuquidar trihydrochloride MeSH Supplementary Concept Data 2025


MeSH Supplementary
zosuquidar trihydrochloride
Unique ID
C095179
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C095179
Entry Term(s)
(2R)-anti-5-(3-(4-(10,11-difluoromethanodibenzo-suber-5-yl)piperazin-1-yl)2-hydroxypropoxy)quinoline trihydrochloride
LY 335979
LY335979
RS 33295-198
RS-33295-198
Registry Numbers
813AGY3126
Heading Mapped to
*Dibenzocycloheptenes
*Quinolines
Frequency
96
Note
multidrug resistance modulator; structure in first source
Source
Anticancer Res 1995 May-Jun;15(3):811-4
Indexing Information
Drug Resistance, Multiple
Date of Entry
1995/09/18
Revision Date
2012/11/05
zosuquidar trihydrochloride Preferred
RS 33295-198 Narrower
LY335979 Narrower
page delivered in 0.004s